A Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21)
Clinical trial NCT03359213 · COMPLETED
Trial details
- NCT number
- NCT03359213
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-26
- Primary completion
- 2019-10-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.